课题基金 / 基金详情

Characterization of human islet cells: functional and transcriptional studies

Characterization of human islet cells: functional and transcriptional studies
人类胰岛细胞的表征:功能和转录研究
批准号:
G0801995/1
负责人:
Olof Rorsman
金额:
$75.17万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

Olof Rorsman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pancreatic islets play a central role in plasma glucose regulation. They do so by secreting several hormones with key role in glucose homeostasis. In addition, the islet delta-cells secrete somatostatin, a peptide hormone that inhibits both insulin and glucagon release. Type-2 diabetes involves disturbances of both insulin and glucagon release. Studies on rodent islets have revealed the fundamental principles about how changes in plasma glucose levels stimulate or inhibit pancreatic islet hormone secretion. It is generally assumed ? without much justification - that data emanating from rodent studies can be extrapolated to man. The Human Islet Transplantation Centre in Oxford is one of two islet isolation centres in the UK. Via this centre we now have regular supply of high-quality human pancreatic islets. Over the last two years, we have characterized the electrophysiological and secretory characteristics of human beta-cells. We have found that human beta-cells differ from mouse beta-cells in a number of important ways. Collectively, the data obtained so far indicate that it is not possible to extrapolate rodent data to the situation in man. In order to understand the hormone secretion defects that associate with type-2 diabetes in man (rodent diabetes is a rare clinical disorder!), we require a much more detailed picture of the functional characteristics of human islet cells. This information should be highly relevant in the ongoing efforts developing new antidiabetic medicines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of impaired glucagon secretion in life-threatening hypoglycaemia of type 1 diabetes: mechanism and therapeutic potential
  • 批准号:
    MR/V011979/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $129.98万
  • 财政年份:
    2021
  • 负责人:
    Olof Rorsman
  • 依托单位:
国内基金
海外基金
靶向Human ZAG蛋白的降糖小分子化合物筛选以及疗效观察
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胡文静
  • 依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
  • 批准号:
    82370885
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨
  • 依托单位:
自闭症相关基因CHD8在非人灵长类大脑发育中的作用
HBV S-Human ESPL1融合基因在慢性乙型肝炎发病进程中的分子机制研究
  • 批准号:
    81960115
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    34.0万元
  • 批准年份:
    2019
  • 负责人:
    江建宁
  • 依托单位: